Results 261 to 270 of about 130,661 (316)

Tacrolimus overdosing in lung transplant recipients: clinical manifestations and management. [PDF]

J Thorac Dis
Chatzidaki E, Schuurmans MM, Bonzon J, Hage R.   +3 more
europepmc   +1 more source

Corrigendum to Development and Evaluation of Tacrolimus Loaded Nano-Transferosomes for Skin Targeting and Dermatitis Treatment [Journal of Pharmaceutical Sciences 113 (2024) 471–485/XPHS_3228] [PDF]

Jingyu Ren, Tao Liu, Bo Bi, Saba Sohail, Fakhar ud Din   +4 more
openalex   +1 more source

Early Stent Removal at Bedside Decreases Urinary Tract Infection in Kidney Transplant Recipients: A Monocentric Prospective Study

Transplant Infectious Disease, EarlyView.
Early bedside removal of the ureteral stent proved feasible and well tolerated, achieving a high level of patient satisfaction. This approach was associated with a reduced incidence of urinary tract infections, without a statistically significant increase in major urological complications. ABSTRACT Background During kidney transplantation, the use of a
François Audenet, Adrien Panis, Guillaume Fraisse, Charles Dariane, Sophie Hurel, Lucile Amrouche, Dany Anglicheau, Christophe Legendre, Arnaud Mejean, Marc‐Olivier Timsit   +9 more
wiley   +1 more source

Artificial Intelligence and Predictive Modelling for Precision Dosing of Immunosuppressants in Kidney Transplantation. [PDF]

Pharmaceuticals (Basel)
Altynova S, Saliev T, Asanova A, Kozybayeva Z, Rakhimzhanova S, Bolatov A.   +5 more
europepmc   +1 more source

Donor–Recipient Epstein–Barr Virus Serostatus and Time‐Varying Risk of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients

Transplant Infectious Disease, EarlyView.
In a national US kidney transplant cohort, posttransplant lymphoproliferative disorder risk varied dynamically by donor–recipient Epstein–Barr virus serostatus. Donor‐positive/recipient‐negative recipients had the highest sustained risk, while donor‐negative/recipient‐negative recipients faced previously under‐recognized early risk, with PTLD strongly ...
Christie Rampersad, Seyed M. Hosseini‐Moghaddam, S. Joseph Kim   +2 more
wiley   +1 more source

Efficacy of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty: A Systematic Review and Meta-analysis of Comparative Studies. [PDF]

Eye (Lond)
Qedair J, Bawazir R, Alghamdi S.
europepmc   +1 more source

The Role of Belatacept‐Use and Senescence on Infectious and Mortality Complications After Kidney Transplantation

Transplant Infectious Disease, EarlyView.
ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam, Abdinoor Abdi, Wyatt Tarter, Ben Langworthy, Adam Bregman, Karam M. Obeid   +5 more
wiley   +1 more source

Efficacy and safety of tacrolimus in the treatment of interstitial pneumonia with autoimmune features: a retrospective study. [PDF]

Front Pharmacol
Zhao Y, Huang X, Cao X, Luo J, He X, Yang Q, Xiong A.   +6 more
europepmc   +1 more source

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention [PDF]

Noa G. Holtzman, Lauren M. Curtis, Rachel B. Salit, Brian C. Shaffer, Filip Pirsl, Alen Ostojić, Seth M. Steinberg, Eduard Schulz, Jennifer Wilder, Thomas E. Hughes, Jeremy J. Rose, Sarfraz Memon, Robert Korngold, Juan Gea‐Banacloche, Daniel H. Fowler, Frances T. Hakim, Ronald E. Gress, Michael Bishop, Steven Z. Pavletic   +18 more
openalex   +1 more source

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

Transplant Infectious Disease, EarlyView.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni, Andrea Cona, Malgorzata Mikulska, Francesca Pecoraro, Carlotta Piazza, Elda De Vita, Giada Pietrosi, Matteo Bulati, Tiziana Lazzarotto, Mario Luppi   +9 more
wiley   +1 more source